Publicados
Predictive factors of response to infliximab therapy in Brazilian inflammatory bowel disease patients
AcessarActive tuberculosis in inflammatory bowel disease patients: a case–control study
AcessarIBD barriers across the continents: a continent-specific analysis: Latin America
AcessarMulti-utility of therapeutic drug monitoring in inflammatory bowel diseases
AcessarRisk stratification and geographical mapping of Brazilian inflammatory bowel disease patients during the COVID-19 outbreak: Results from a nationwide
AcessarCOVID-19 outcomes in patients with inflammatory bowel diseases in Latin America: Results from SECURE-IBD registry
AcessarPractical Aspects of Proactive TDM for Anti-TNF Agents in IBD: Defining Time Points and Thresholds to Target
AcessarDoutorado em Ciências Médicas em Gastroenterologia pela FM-USP
Residência Médica em Gastroenterologia Clínica no Hospital das Clínicas da FM-USP
Residência Médica em Clínica Médica na Escola Paulista de Medicina
Graduação em Medicina pela Universidade Federal do Ceará